loader
Please Wait
Applying Filters...
menu
    • menu

    Digital Content for Antilysin

    Client Email Product
    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    Bora Pharmaceuticals- Making success more certain.

    Virtual Booth

    Contact Supplier

    Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

    Virtual Booth

    Contact Supplier

    Minakem offers CDMO services for API & HPAPI, generics, regulatory expertise, track record performance & FDA & GMP certifications.

    Virtual Booth

    Contact Supplier

    Axplora- The partner of choice for complex APIs.

    Virtual Booth

    Contact Supplier

    Fareva is a one-stop-shop for API/HPAPI, OSD & Sterile products, is USFDA, EMA and PMDA-inspected and has multiple NDA & ANDA filings.

    Virtual Booth

    Contact Supplier

    Menu

    Antilysin

    ACTIVE PHARMA INGREDIENTS

    PRICE INFORMATION

    FINISHED DOSAGE FORMULATIONS

    DIGITAL CONTENT

    MARKET PLACE

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 96,202Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    EMA Approved aprotinin - List of nationally authorised medicinal products
    EMA Approved aprotinin - List of nationally authorised medicinal products

    12 Nov 2018

    // EMA

    https://www.ema.europa.eu/documents/psusa/aprotinin-list-nationally-authorised-medicinal-products-psusa-00000230-201802_en.pdf

    EMA
    12 Nov 2018
    Share Share
    Edge Therapeutics swings for a $115M IPO with eyes on Phase III
    Edge Therapeutics swings for a $115M IPO with eyes on Phase III

    17 Aug 2015

    // Damian Garde FIERCE BIOTECH

    http://www.fiercebiotech.com/story/edge-therapeutics-swings-115m-ipo-eyes-phase-iii/2015-08-17

    Damian Garde FIERCE BIOTECH
    17 Aug 2015
    Share Share